La Jolla Pharmaceutical Co Stock Price, News & Analysis
Company Description
La Jolla Pharmaceutical Co (NASDAQ: LJPC) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $155.1M.
LJPC stock has gained 70.0% over the past year.
This page provides a comprehensive overview of LJPC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
La Jolla Pharmaceutical Co (LJPC) stock. Over the past 12 months, the stock has gained 70.0%. At a market capitalization of $155.1M, LJPC is classified as a micro-cap stock with approximately 24.9M shares outstanding.
Latest News
La Jolla Pharmaceutical Co has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, buybacks. View all LJPC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LJPC Company Profile & Sector Positioning
La Jolla Pharmaceutical Co (LJPC) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.